SCHEMBL2980353

SCHEMBL2980353

CN(C)C(=O)c1ccc([N+](=O)[O-])cc1S(=O)(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.60
ALDH1A1 P00352 6/20 0.49
CYP3A4 P08684 3/20 0.49
ALOX15 P16050 2/20 0.49
PDE2A O00408 1/20 0.49
PDE5A O76074 1/20 0.49
NFKB1 P19838 1/20 0.49
APEX1 P27695 1/20 0.49
PDE4A P27815 1/20 0.49
BLM P54132 1/20 0.49
PDE1B Q01064 1/20 0.49
PMP22 Q01453 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4D Q08499 1/20 0.49
PDE7A Q13946 1/20 0.49
PDE1C Q14123 1/20 0.49
PDE7B Q9NP56 1/20 0.49
KMT2A Q03164 3/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL2975285 1.00 L3MBTL1 (0.60) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
SCHEMBL2970344 0.99 L3MBTL1 (0.58) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
Potassium SCHEMBL2975289 0.99 L3MBTL1 (0.58) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
SCHEMBL2970353 0.99 L3MBTL1 (0.58) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
Potassium SCHEMBL7658381 0.90 L3MBTL1 (0.50) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
Potassium Ion SCHEMBL2975282 0.88 L3MBTL1 (0.60) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
SCHEMBL4620526 0.87 L3MBTL1 (0.62) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
SCHEMBL6105510 0.87 L3MBTL1 (0.58) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
SCHEMBL2970340 0.87 L3MBTL1 (0.58) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A
Potassium Ion SCHEMBL7658373 0.87 L3MBTL1 (0.47) L3MBTL1ALDH1A1CYP3A4ALOX15PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781611-B2 Nitro-sulfobenzamides AVENTIS CROPSCIENCE GMBH (DE) 2010-08-24 US disclosed
EP-1242386-B1 NITRO-SULFOBENZAMIDES BAYER CROPSCIENCE AG (DE) 2009-08-26 EP disclosed
US-20010020092-A1 Nitro-sulfobenzamides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2001-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020092-A1 Nitro-sulfobenzamides SULT1A1, SULT2A1, SULT1E1 L3MBTL1 3689/4885ALDH1A1 605/4885CYP3A4 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.